Showing results (1-10 of 126) with videos related to
Sort By:
Pageof 13
Current Opinion in Investigational Drugs (London, England : 2000)|May 22, 2002
DPC-423 Bristol-Myers SquibbMaurizio TaglialatelaFrontiers in Physiology|December 3, 2013
New advances in beta-blocker therapy in heart failureVincenzo Barrese, Maurizio TaglialatelaCNS Drugs|January 24, 2025
Targeting Kv7 Potassium Channels for EpilepsyEmilio Perucca, Maurizio TaglialatelaBritish Journal of Pharmacology|January 29, 2021
Neurological risks and benefits of cytokine-based treatments in coronavirus disease 2019: from preclinical to clinical evidenceGiuseppe Pignataro, Mauro Cataldi, Maurizio TaglialatelaNeuropharmacology|May 16, 2006
Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal culturesFrancesca Boscia, Lucio Annunziato, Maurizio TaglialatelaNeurobiology of Disease|July 5, 2020
Neurobiology of coronaviruses: Potential relevance for COVID-19Mauro Cataldi, Giuseppe Pignataro, Maurizio TaglialatelaPhysiology (Bethesda, Md.)|October 21, 2011
Driving with no brakes: molecular pathophysiology of Kv7 potassium channelsMaria Virginia Soldovieri, Francesco Miceli, Maurizio TaglialatelaChemical Research in Toxicology|April 30, 2008
Cardiotoxic effects of antihistamines: from basics to clinics (...and back)Maria Virginia Soldovieri, Francesco Miceli, Maurizio TaglialatelaFrontiers in Physiology|November 16, 2020
The Role of Kv7.2 in Neurodevelopment: Insights and Gaps in Our UnderstandingNina Dirkx, Francesco Miceli, Maurizio Taglialatela, et al.Biophysical Journal|March 30, 2012
Gating currents from Kv7 channels carrying neuronal hyperexcitability mutations in the voltage-sensing domainFrancesco Miceli, Ernesto Vargas, Francisco Bezanilla, et al.Pageof 13